AstraZeneca PLC (AZN) annual results, year to 31 December 2016: revenue USD 23,002 million, from the 20-F
AstraZeneca PLC files a 20-F with the SEC once a year, in US dollars. In the year to 31 December 2016 it reported revenue of USD 23,002 million, down 6.9% on the year before. Its profit attributable to shareholders was USD 3,499 million, up 23.9%, and diluted earnings per share USD 2.76.
this yearthe year beforeIn US dollars as filed. Hover a bar for its figure.
Income statement (profit and loss)
| Year to | Dec 2015 | Dec 2016 |
|---|---|---|
| Revenue | 24,708 | 23,002 |
| Cost of sales | 4,646 | 4,126 |
| Gross profit | 20,062 | 18,876 |
| Research and development | 5,997 | 5,890 |
| Selling, general and administrative | 11,112 | 9,413 |
| Operating profit | 4,114 | 4,902 |
| Finance costs | 1,075 | 1,384 |
| Profit before tax | 3,069 | 3,552 |
| Income tax | 243 | 146 |
| Profit for the year | 2,826 | 3,406 |
| Profit attributable to shareholders | 2,825 | 3,499 |
| Filing | 20-F | 20-F |
USD million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read more
A line the company does not file under the standard tag is left out rather than estimated.USD per ordinary share, as filed.
Cash flow
| Year to | Dec 2015 | Dec 2016 |
|---|---|---|
| Cash from operations | 3,324 | 4,145 |
| Purchase of property, plant and equipment | 1,328 | 1,446 |
| Free cash flow | 1,996 | 2,699 |
| Cash from investing | -4,239 | -3,969 |
| Cash from financing | 878 | -1,324 |
| Dividends paid | 3,486 | 3,561 |
| Filing | 20-F | 20-F |
USD million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.
Balance sheet
| Year to | Dec 2015 | Dec 2016 |
|---|---|---|
| Funded by | ||
| Equity attributable to shareholders | 18,490 | 14,854 |
| Non-controlling interests | 19.0 | 1,815 |
| Borrowings, as filed | 15,053 | 16,808 |
| Other liabilities | 26,494 | 29,049 |
| Total equity and liabilities | 60,056 | 62,526 |
| Owned | ||
| Property, plant and equipment | 6,413 | 6,848 |
| Goodwill | 11,800 | 11,658 |
| Other intangible assets | 22,646 | 27,586 |
| Cash and cash equivalents | 6,240 | 5,018 |
| Trade and other receivables | 6,622 | 4,573 |
| Inventories | 2,143 | 2,334 |
| Other assets | 4,192 | 4,509 |
| Total assets | 60,056 | 62,526 |
| Filing | 20-F | 20-F |
USD million, at each fiscal year end.
Ratios on the filed lines
| Year to | Dec 2015 | Dec 2016 |
|---|---|---|
| Gross margin | 81.2% | 82.1% |
| Operating margin | 16.7% | 21.3% |
| Net margin | 11.4% | 15.2% |
| Free cash flow margin | 8.1% | 11.7% |
| Return on year-end equity | 15.3% | 23.6% |
| Effective tax rate | 7.9% | 4.1% |
| Filing | 20-F | 20-F |
Arithmetic on the filed lines of the same year.
20-F for the year to 31 December 2016, filed 5 March 2019: the filing. The figures are in US dollars as filed.